{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:15:04Z","timestamp":1783703704975,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jpba.2015.01.059","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T02:59:08Z","timestamp":1424228348000},"page":"36-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form"],"prefix":"10.1016","volume":"109","author":[{"given":"Ji\u0159\u00ed","family":"Vojta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ale\u0161","family":"Jedli\u010dka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Coufal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Jane\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2015.01.059_bib0305","series-title":"A Global Brief on Hypertension","year":"2013"},{"key":"10.1016\/j.jpba.2015.01.059_bib0310","first-page":"1462","volume":"28","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jpba.2015.01.059_bib0315","series-title":"Color Atlas of Pharmacology","author":"L\u00fcllman","year":"2000"},{"key":"10.1016\/j.jpba.2015.01.059_bib0320","series-title":"Lecture Notes, Clinical Pharmacology and Therapeutics","author":"McKay","year":"2013"},{"key":"10.1016\/j.jpba.2015.01.059_bib0325","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpba.2007.10.038","article-title":"Drug safety, drug quality, drug analysis","volume":"48","author":"Gorog","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.01.059_bib0330","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2006.10.003","article-title":"Assuring quality of drugs by monitoring impurities","volume":"59","author":"Ahuja","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpba.2015.01.059_bib0335","first-page":"1365","article-title":"UPLC versus HPLC on drug analysis: advantageous","volume":"76","author":"Gumustas","year":"2013","journal-title":"Appl. Valid. Parameters Chromatogr."},{"key":"10.1016\/j.jpba.2015.01.059_bib0340","series-title":"European Directorate for the Quality of Medicines & HealthCare","author":"European Pharmacopoeia","year":"2014"},{"key":"10.1016\/j.jpba.2015.01.059_bib0345","unstructured":"USP 37, The United States Pharmacopeial Convention, 2014."},{"key":"10.1016\/j.jpba.2015.01.059_bib0350","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jpba.2010.05.022","article-title":"Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms","volume":"53","author":"Krishnaiah","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.01.059_bib0355","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jpba.2013.10.029","article-title":"Reliability of simulated robustness testing in fast liquid chromatography, using state-of-the-art column technology, instrumentation and modelling software","volume":"89","author":"Kormany","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.01.059_bib0360","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1080\/10826070701588638","article-title":"Monitoring of impurity level of valsartan and hydrochlorothiazide emloying RP-HPLC gradient mode","volume":"30","author":"Ivanovic","year":"2007","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2015.01.059_bib0365","first-page":"284","article-title":"Tablet formulation and development of a validated stability indicating HPLC method for quantification of valsartan and hydrochlorothiazide combination","volume":"4","author":"Kharoaf","year":"2012","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jpba.2015.01.059_bib0370","first-page":"1","article-title":"UPLC method for simultaneous determination of Valsartan & Hydrochlorothiazide in drug products","volume":"4","author":"Antil","year":"2013","journal-title":"J. Chromatogr. Sep. Technol."},{"key":"10.1016\/j.jpba.2015.01.059_bib0375","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/10826076.2012.738620","article-title":"Quantitative determination of four angiotensin-II-receptor antagonists in presence of hydrochlorothiazide by a gradient technique HPLC in their pharmaceutical preparations","volume":"37","author":"Elshanawane","year":"2014","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2015.01.059_bib0380","first-page":"468","article-title":"Stability indicating HPTLC method for simultaneous determination of Valsartan and Hydrochlorothiazide in tablets","volume":"4","author":"Singh","year":"2012","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jpba.2015.01.059_bib0385","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.talanta.2011.01.066","article-title":"Dual separation mode for simultaneous determination of antihypertensive drug combinations by high-performance liquid chromatography","volume":"84","author":"Ahmed","year":"2011","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2015.01.059_bib0390","first-page":"762","article-title":"TLC simultaneous determination of valsartan and hydrochlorothiazide in pure form and in tablets using butyl-modified Aleppo Bentonite","volume":"5","author":"Ramadan","year":"2013","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jpba.2015.01.059_bib0395","first-page":"102","article-title":"A stability indicating RP-HPLC method with shorter runtime for simultaneous estimation of Valsartan and Amlodipine from their combination drug product","volume":"1","author":"Prasad","year":"2011","journal-title":"Int. J. Res. Pharm. Chem."},{"key":"10.1016\/j.jpba.2015.01.059_bib0400","first-page":"15","article-title":"Stability indicating RP-HPLC method for simultaneous estimation of Valsartan and Amlodpine in capsule formulation","volume":"1","author":"Chitlange","year":"2008","journal-title":"Asian J. Res. Chem."},{"key":"10.1016\/j.jpba.2015.01.059_bib0405","first-page":"335","article-title":"Rapid determination of amlodipine besylate and valsartan in pharmaceutical preparations by stability-indicating ultra performance liquid chromatography","volume":"11","author":"Reddy","year":"2012","journal-title":"Anal. Chem.: Indian J."},{"key":"10.1016\/j.jpba.2015.01.059_bib0410","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1365\/s10337-008-0858-1","article-title":"Validated TLC method for simultaneous quantitation of amlodipine besylate and valsartan in bulk drug and formulation","volume":"69","author":"Dhaneshwar","year":"2009","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2015.01.059_bib0415","first-page":"129","article-title":"Simultaneous determination of amlodipine besylate and valsartan in pharmaceutical formulation using high performance liquid chromatography","volume":"2","author":"Al-Shaalan","year":"2010","journal-title":"J. Chem. Pharm. Res."},{"key":"10.1016\/j.jpba.2015.01.059_bib0420","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/00032710903406953","article-title":"Rapid and highly sensitive HPLC and TLC methods for quantitation of amlodipine besilate and valsartan in bulk powder and in pharmaceutical dosage forms and in human plasma","volume":"43","author":"Ramadan","year":"2010","journal-title":"Anal. Lett."},{"key":"10.1016\/j.jpba.2015.01.059_bib0425","first-page":"19","article-title":"RP-HPLC method for simultaneous determination of amlodipine besylate and valsartan in pharmaceutical dosage form","volume":"60","author":"Peikova","year":"2013","journal-title":"Pharmacia (Sofia)"},{"key":"10.1016\/j.jpba.2015.01.059_bib0430","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/chromsci\/bms067","article-title":"Stability-indicating method for simultaneous estimation of olmesartan medoxomile, amlodipine besylate and hydrochlorothiazide by RP-HPLC in tablet dosage form","volume":"50","author":"Jain","year":"2012","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2015.01.059_bib0435","first-page":"145","article-title":"Development and validation of stability indicating HPLC assay method for simultaneous determination of amlodipine besylate, olmesartan medoxomil and hydrochlorothiazide in tablet formulation","volume":"4","author":"Pandya","year":"2013","journal-title":"Pharm. Sin."},{"key":"10.1016\/j.jpba.2015.01.059_bib0440","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1556\/JPC.25.2012.5.16","article-title":"Stability-indicating HPTLC method for simultaneous estimation of amlodipine besylate, hydrochlorothiazide and olmesartan medoxomil in combined tablet dosage forms","volume":"25","author":"Dubey","year":"2012","journal-title":"J. Planar Chromatogr. Mod. TLC"},{"key":"10.1016\/j.jpba.2015.01.059_bib0445","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10337-013-2592-6","article-title":"Ion-pair LC method for simultaneous determination of aliskiren hemifumarate, amlodipine besylate and hydrochlorothiazide in pharmaceuticals","volume":"77","author":"El-Bagary","year":"2014","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2015.01.059_bib0450","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/jssc.201301140","article-title":"Simultaneous determination of aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide in their triple mixture dosage form by capillary zone electrophoresis","volume":"37","author":"Salim","year":"2014","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2015.01.059_bib0455","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0731-7085(02)00385-0","article-title":"Development and validation of a stability-indicating HPLC method for the simultaneous determination of Losartan potassium, hydrochlorothiazide, and their degradation products","volume":"30","author":"Hertzog","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.01.059_bib0460","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4103\/0975-7406.84441","article-title":"Simultaneous determination of related substances of telmisartan and hydrochlorothiazide in tablet dosage form by using reversed phase high performance liquid chromatographic method","volume":"3","author":"Mukhopadhyay","year":"2011","journal-title":"J. Pharm. BioAllied Sci."},{"key":"10.1016\/j.jpba.2015.01.059_bib0465","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1080\/10826076.2011.582210","article-title":"Simultaneous determination of eprosartan, hydrochlorothiazide, and their related compounds in pharmaceutical dosage forms by UPLC","volume":"34","author":"Satheesh","year":"2011","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2015.01.059_bib0470","first-page":"143","article-title":"Validation of an analytical procedure for simultaneous determination of hydrochlorothiazide, lisinopril, and their impurities","volume":"18","author":"Ivanovic","year":"2007","journal-title":"Acta Chromatogr."},{"key":"10.1016\/j.jpba.2015.01.059_bib0475","first-page":"454","article-title":"Simultaneous determination of lisinopril and hydrochlorothiazide related impurities in lisinopril and hydrochlorothiazide combined tablet dosage forms using HPLC","volume":"7","author":"Aparna","year":"2008","journal-title":"Anal. Chem.: Indian J."},{"key":"10.1016\/j.jpba.2015.01.059_bib0480","first-page":"458","article-title":"New stability indicating method for quantification of impurities in Amlodipine and Atorvastatin calcium tablets by validated HPLC","volume":"2","author":"Eranki","year":"2013","journal-title":"Int. J. Pharm. Res. Sch."},{"key":"10.1016\/j.jpba.2015.01.059_bib0485","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4236\/ajac.2013.412086","article-title":"New stability indicating method for quantification of impurities in Amlodipine and Benazepril capsules by validated HPLC","volume":"4","author":"Eranki","year":"2013","journal-title":"Am. J. Anal. Chem."},{"key":"10.1016\/j.jpba.2015.01.059_bib0490","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/10826076.2011.597071","article-title":"Gradient HPLC-DAD determination of the antihypertensive mixture of amlodipine besylate, valsartan, and hydrochlorothiazide in combined pharmaceutical tablets","volume":"35","author":"Shaalan","year":"2012","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2015.01.059_bib0495","article-title":"Development of an HPLC\u2013UV method for the analysis of drugs used for combined hypertension therapy in pharmaceutical preparations and human plasma","author":"Tekkeli","year":"2013","journal-title":"J. Anal. Methods Chem."},{"issue":"12","key":"10.1016\/j.jpba.2015.01.059_bib0500","article-title":"Validated RP-HPLC method for the simultaneous determination of amlodipine besylate, valsartan and hydrochlorothiazide in bulk and in pharmaceutical formulation","volume":"5","author":"Jothieswari","year":"2012","journal-title":"J. Pharm. Biomed. Sci."},{"key":"10.1016\/j.jpba.2015.01.059_bib0505","first-page":"174","article-title":"Method development and validation of simultaneous estimation of Amlodipine besylate, Valsartan and Hydrochlorothiazide in pure drug and pharmaceutical formulations by using RP-HPLC","volume":"2","author":"Deepthi","year":"2013","journal-title":"Int. J. Univ. Pharm. Biosci."},{"key":"10.1016\/j.jpba.2015.01.059_bib0510","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4236\/ajac.2012.36055","article-title":"Development and validation of HPLC method for simultaneous determination of amlodipine, valsartan, hydrochlorothiazide in dosage form and spiked human plasma","volume":"3","author":"El-Gizawy","year":"2012","journal-title":"Am. J. Anal. Chem."},{"key":"10.1016\/j.jpba.2015.01.059_bib0515","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2478\/v10007-012-0004-3","article-title":"Simple RP-HPLC method for determination of triple drug combination of valsartan, amlodipine and hydrochlorothiazide in human plasma","volume":"62","author":"Sharma","year":"2012","journal-title":"Acta Pharm. (Zagreb)"},{"key":"10.1016\/j.jpba.2015.01.059_bib0520","first-page":"894","article-title":"Single RP-HPLC method for the determination of hydrochlorothiazide, amlodipine besylate and valsartan in pharmaceutical products","volume":"4","author":"Ulavapally","year":"2011","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.jpba.2015.01.059_bib0525","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/chromsci\/bms200","article-title":"Concurrent estimation of amlodipine besylate, hydrochlorothiazide and valsartan by RP-HPLC, HPTLC and UV spectrophotometry","volume":"52","author":"Sharma","year":"2014","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2015.01.059_bib0530","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10337-013-2598-0","article-title":"RP-HPLC method for the simultaneous estimation of eight cardiovascular drugs","volume":"77","author":"Vishnuvardhan","year":"2014","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2015.01.059_bib0535","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1080\/10826076.2011.591020","article-title":"Development and validation of an HPLC method for the simultaneous determination of amlodipine, hydrochlorothiazide, and valsartan in tablets of their novel triple combination and binary pharmaceutical associations","volume":"34","author":"Vignaduzzo","year":"2011","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2015.01.059_bib0540","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/10826076.2011.565539","article-title":"Quantitative simultaneous determination of amlodipine, valsartan, and hydrochlorothiazide in Exforge HCT tablets using high-performance liquid chromatography and high-performance thin-layer chromatography","volume":"34","author":"Varghese","year":"2011","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2015.01.059_bib0545","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/jssc.201301298","article-title":"Synchronized separation of seven medications representing most commonly prescribed antihypertensive classes by using reversed-phase liquid chromatography: application for analysis in their combined formulations","volume":"37","author":"Ebeid","year":"2014","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2015.01.059_bib0550","first-page":"440","article-title":"High resolution RP-HPLC method for the determination of hypertensive drug products","volume":"4","author":"Phani","year":"2013","journal-title":"Int. J. Pharm. Biol. Sci."},{"key":"10.1016\/j.jpba.2015.01.059_bib0555","first-page":"345","article-title":"Rapid and sensitive TLC and HPLC with on-line wavelength switching methods for simultaneous quantitation of Amlodipine, Valsartan and Hydrochlorothiazide in pharmaceutical dosage forms","volume":"4","author":"Darwish","year":"2013","journal-title":"Int. J. Pharm. Biol. Sci."},{"key":"10.1016\/j.jpba.2015.01.059_bib0560","first-page":"2647","article-title":"RP-HPLC method development and validation for simultaneous estimation of amlodipine besylate, valsartan and hydrochlorothiazide in tablet dosage form","volume":"3","author":"Younus","year":"2010","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.jpba.2015.01.059_bib0565","first-page":"5383","article-title":"Validated RP-HPLC method for simultaneous determination of Amlodipine, Hydrochlorothiazide and Valsartan in pharmaceutical formulation","volume":"5","author":"Hemke","year":"2013","journal-title":"Int. J. Pharm. Technol."},{"key":"10.1016\/j.jpba.2015.01.059_bib0570","first-page":"642","article-title":"Simultaneous estimation of valsartan, amlodipine besylate and hydrochlorothiazide by first order derivative UV spectrophotometric method","volume":"2","author":"Nikam","year":"2010","journal-title":"Int. J. Pharm. Technol."},{"key":"10.1016\/j.jpba.2015.01.059_bib0575","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.saa.2013.04.068","article-title":"Comparative study between derivative spectrophotometry and multivariate calibration as analytical tools applied for the simultaneous quantitation of Amlodipine, Valsartan and Hydrochlorothiazide","volume":"113","author":"Darwish","year":"2013","journal-title":"Spectrochim. Acta A"},{"key":"10.1016\/j.jpba.2015.01.059_bib0580","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/0250-474X.102538","article-title":"Estimation of amlodipine besylate, valsartan and hydrochlorothiazide in bulk mixture and tablet by UV spectrophotometry","volume":"74","author":"Galande","year":"2012","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2015.01.059_bib0585","unstructured":"USP 37 Second supplement, The United States Pharmacopeial Convention, 20.10.2014."},{"key":"10.1016\/j.jpba.2015.01.059_bib0590","series-title":"ICH Q2 (R1) Validation of Analytical Procedures: Text and Methodology","year":"2005"},{"key":"10.1016\/j.jpba.2015.01.059_bib0595","series-title":"HPLC for Pharmaceutical Scientists","first-page":"455","article-title":"Method validation","author":"LoBrutto","year":"2007"},{"key":"10.1016\/j.jpba.2015.01.059_bib0600","series-title":"Handbook of Modern Pharmaceutical Analysis","first-page":"415","article-title":"Validation of pharmaceutical test method","author":"Crowther","year":"2001"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515001120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515001120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T01:19:28Z","timestamp":1566350368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708515001120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":60,"alternative-id":["S0731708515001120"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2015.01.059","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2015.01.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}